Trial Profile
Neurophysiological assessment of the effect of Sativex (THC/CBD oromucosal spray) as add-on to treat spasticity following stroke Valutazione neurofisiologica dell'effetto del Sativex (THC/CBD Spray oromucosale) come trattamento aggiuntivo della spasticità post-ictus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2022
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms SativexStroke
- 03 Apr 2022 Status changed from recruiting to completed.
- 27 Sep 2018 New trial record